• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number UNK SJM TRIFECTA VALVE
Device Problems Degraded (1153); Perivalvular Leak (1457); Patient-Device Incompatibility (2682); Patient Device Interaction Problem (4001); Material Split, Cut or Torn (4008)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/01/1998
Event Type  malfunction  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Literature attachment: article title "prosthetic valve endocarditis after aortic valve replacement: differences between biological and mechanical prostheses.
 
Event Description
The article, "prosthetic valve endocarditis after aortic valve replacement: differences between biological and mechanical prostheses", was reviewed.The article presented a single center, retrospective study to compare the incidence of re-intervention because of prosthetic valve endocarditis (pve) between bioprosthetic and mechanical valves.Devices included mitroflow, trifecta, sjm epic, carpentier edwards perimount magna ease, mosaic, ats mechanical valve, sjm regent, and sorin bicarbon slimline/carboseal valsalva.The article concluded that according to this single-center, observational, retrospective cohort study, aortic valve replacement (avr) using biological prosthesis is associated with re-intervention for pve compared to mechanical prosthesis.Further investigations are needed to verify these findings.[the primary and corresponding author was (b)(6) hospital eindhoven, eindhoven, the netherlands, with corresponding email: (b)(6).The time frame of the study was from january 1998 to december 2019 with the end date of follow up on (b)(6) 2020.A total of (b)(6) patients were included in the study, of which 42.4% received an abbott device.The average age was 73.1 years for the biological prosthesis group and 61.4 years for mechanical prosthesis group.The average gender was male.Comorbidities included prior cardiac surgery, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, prior stroke, peripheral arterial disease, and dialysis.
 
Manufacturer Narrative
Summarized patient outcomes/complications of prosthetic valve endocarditis after aortic valve replacement: differences between biological and mechanical prostheses were reported in a research article in a subject population with multiple co-morbidities including prior cardiac surgery, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, prior stroke, peripheral arterial disease, and dialysis.Some of the complications reported were surgical intervention, hospitalization, bleeding, myocardial infarction, stroke, abscess, paravalvular leak, endocarditis, thrombus, pannus, cusp tear, structural valve deterioration; these complications are anticipated for the procedure and subject population.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18565585
MDR Text Key333505292
Report Number2135147-2024-00333
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/23/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK SJM TRIFECTA VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/26/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization; Disability;
-
-